- Home
- INBX vs EMX Comparison
INBX vs EMX Comparison
Compare INBX & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- EMX
- Stock Information
- Founded
- INBX 2010
- EMX N/A
- Country
- INBX United States
- EMX Canada
- Employees
- INBX N/A
- EMX N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- EMX
- Sector
- INBX Health Care
- EMX
- Exchange
- INBX Nasdaq
- EMX Nasdaq
- Market Cap
- INBX 345.8M
- EMX 338.0M
- IPO Year
- INBX 2020
- EMX N/A
- Fundamental
- Price
- INBX $27.52
- EMX $4.18
- Analyst Decision
- INBX Hold
- EMX Strong Buy
- Analyst Count
- INBX 2
- EMX 2
- Target Price
- INBX N/A
- EMX $5.38
- AVG Volume (30 Days)
- INBX 113.1K
- EMX 959.7K
- Earning Date
- INBX 11-13-2025
- EMX 11-06-2025
- Dividend Yield
- INBX N/A
- EMX N/A
- EPS Growth
- INBX N/A
- EMX N/A
- EPS
- INBX N/A
- EMX 0.04
- Revenue
- INBX $1,400,000.00
- EMX $29,864,000.00
- Revenue This Year
- INBX N/A
- EMX $11.08
- Revenue Next Year
- INBX N/A
- EMX $3.72
- P/E Ratio
- INBX N/A
- EMX $93.86
- Revenue Growth
- INBX N/A
- EMX N/A
- 52 Week Low
- INBX $10.81
- EMX $1.64
- 52 Week High
- INBX $30.23
- EMX $4.44
- Technical
- Relative Strength Index (RSI)
- INBX 58.56
- EMX 72.14
- Support Level
- INBX $27.51
- EMX $4.01
- Resistance Level
- INBX $30.23
- EMX $4.44
- Average True Range (ATR)
- INBX 1.47
- EMX 0.18
- MACD
- INBX -0.09
- EMX 0.04
- Stochastic Oscillator
- INBX 54.53
- EMX 77.19
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.